Head-off Environmental Asthma in Louisiana (HEAL) Phase II Project

HEAL, Phase II Funders

Merck Childhood Asthma Network (MCAN)
The Merck Childhood Asthma Network, Inc. (MCAN) is a separately incorporated, non-profit, 501(c)(3) organization established to address the complex and growing problem of pediatric asthma. HEAL Phase II is funded by MCAN which, in turn, is funded by the Merck Company Foundation. For more information, visit www.mcanonline.org.

The Merck Company Foundation
The Merck Company Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, the Foundation is funded entirely by the company and is Merck's chief source of funding support to qualified non-profit, charitable organizations. Since its inception, the Foundation has contributed more than $600 million to support important initiatives that address societal needs and are consistent with the company'Äôs overall mission to help the world be well. For more information, visit www.merckresponsibility.com.

"My personal and professional experience with asthma won't let me sit idly by while children with asthma fall off the healthcare radar screen. It is now more important than ever that we encourage collaboration, and gather the resources and commitments necessary to successfully address this issue

Floyd J. Malveaux, MD, PhD
Executive Director
Merck Childhood Asthma Network, Inc

Head-off Environmental Asthma in Louisiana (HEAL) Phase II Project